摘要：SummaryWe carried out a genome-wide association analysis including 51,194 cases of hypothyroidism and 443,383 controls. In total, 139 risk loci were associated to hypothyroidism with genes involved in lymphocyte function. Candidate genes associated with hypothyroidism were identified by using molecular quantitative trait loci, colocalization, and enhancer-promoter chromatin looping. Mendelian randomization (MR) identified 42 blood expressed genes and circulating proteins as candidate causal molecules in hypothyroidism. Drug-gene interaction analysis provided evidence that immune checkpoint and tyrosine kinase inhibitors used in cancer therapy increase the risk of hypothyroidism. Hence, integrative mapping and MR support that expression of genes and proteins enriched in lymphocyte function are associated with the risk of hypothyroidism and provide genetic evidence for drug-induced hypothyroidism and identify actionable potential drug targets.Graphical abstractDisplay OmittedHighlights•GWAS for hypothyroidism identified 139 risk loci including 76 novel associations•GWAS was enriched in pathways related to lymphocyte function•In total, 28 potentially deleterious missense variants were identified•Mendelian randomization and colocalization identified 61 blood causal candidate genesClinical genetics; Genomics; Molecular genetics
